Home › Mieloma multiplo › Wisconsin
Studi clinici su Mieloma multiplo nello stato di Wisconsin
28 studi su Mieloma multiplo cercano partecipanti presso sedi nello stato di Wisconsin.
Città nello stato di Wisconsin
Testo ufficiale dello studio (inglese)
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Mayo Clinic Health System-Eau Claire Clinic, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06630104A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Research Site, Madison
- Research Site, Milwaukee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07391657A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- University of Wisconsin Carbone Cancer Center, Madison
- Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT04973605A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Medical College Of Wisconsin, Milwaukee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07258511A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Froedtert Memorial, Milwaukee
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05201781A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
- The Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07116616TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Aurora Cancer Care - Burlington, Burlington
- Aurora Health Care - Germantown Health Center, Germantown
- Aurora Cancer Care - Grafton, Grafton
- e altri 13
In reclutamentoFase 2
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT02693535Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Medical College of Wisconsin, Milwaukee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07648264A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Medical College of Wisconsin, Milwaukee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT06615479Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06297226Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
- University of Wisconsin, Madison
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07479979A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Research Site, Milwaukee
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07681596MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center-University Hospital, Madison
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT06152575Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- ThedaCare Regional Cancer Center, Appleton
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
- e altri 47
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT04566328Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Gundersen Lutheran, La Crosse
In reclutamentoFase 3
Età da 18 a 79 · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT07285239AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Milwaukee
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05850234Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1
Età da 18 a 80 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT05976555A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Wisconsin - Carbone Cancer Center, Madison
- MCW-Clinical Cancer Center at Froedtert Hospital Campus, Milwaukee
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT07284758Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
- Medical College of Wisconsin, Milwaukee
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT07236502Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Langlade Hospital and Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- e altri 22
In reclutamentoFase 3
Tutte le età · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT05561387Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- St Vincent HSHS (Green Bay Oncology), Green Bay
- University of Wisconsin Hospital and Clinics, Madison
- Froedtert Memorial Lutheran Hospital, Milwaukee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 giu 2026 · NCT05243797Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
- University of Wisconsin Clinical Science Center, Madison
- Medical College of Wisconsin, Milwaukee
In reclutamentoFase 2
Età 19 e oltre · Tutti i sessi · Aggiornato il 4 giu 2026 · NCT06974786Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 apr 2026 · NCT05862012Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 gen 2026 · NCT04240054Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 gen 2026 · NCT07093554Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
In reclutamentoStudio osservazionale
Età da 18 a 80 · Tutti i sessi · Aggiornato il 10 nov 2025 · NCT03375619CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert and the Medical College of Wisconsin, Milwaukee
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2025 · NCT05722418Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.